Related Experiment Video
Updated: May 23, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Scleroderma-like syndrome due to hydroxyurea
F J García-Martínez1, J García-Gavín, A Alvarez-Pérez
1Department of Dermatology, Faculty of Medicine, Complejo Hospitalario Universitario, Santiago de Compostela, Spain. fjgarcia@aedv.es
Abstract:
Scleroderma-like cutaneous changes have been reported in association with several drugs, but not with hydroxyurea (HU), to our knowledge. We report the case of a 67-year-old man who was treated with HU (hydroxycarbamide) for 12 years for a myeloproliferative disorder, and presented a progressive pruritic woody induration, symmetrically affecting both legs. He also had Gottron-like papules on the back of the metacarpophalangeal joints, and a retroauricular undifferentiated squamous cell carcinoma. On histological examination of a skin biopsy taken from the leg, massive dermal fibrosis was seen, with thickening of collagen bundles throughout the entire dermis. Six months after HU withdrawal, the skin induration resolved without scarring. Scleroderma-like syndrome has not been previously considered one of the secondary effects of HU. The evolution of our patient's condition supports a causal relationship between the HU treatment and the sclerodermiform changes of the skin.
Related Concept Videos
Hyperosmolar Hyperglycemic State
Chronic Kidney Disease II: Clinical Manifestations
Huntington Disease l: Introduction
Hemodialysis II: Procedure and Complications
Nephrotic Syndrome I : Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy